Intellia Therapeutics, Inc. (0JBU.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 986.22M |
| Enterprise Value | 990.94M |
| P/E Ratio | -3.64 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 28.72 |
| Price/Book Ratio | 2.24 |
| Enterprise/Revenue | 28.17 |
| Enterprise/EBITDA | -4.29 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -6.72 |
| Operating Margin | -7.12 |
AD
Management Effectiveness
| Return On Assets | -0.47 |
| Return On Equity | -0.58 |
Income Statement
| Revenue | 67.67M |
| Revenue/Share | 0.45 |
| Gross Profit | 51.75M |
| EBITDA | -425.07M |
| Net Income | -412.69M |
| Diluted EPS | -3.81 |
Balance Sheet
| Total Cash | 437.76M |
| Total Cash/Share | 3.28 |
| Total Debt | 73.41M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 6.65 |
| Book Value Per Share | 5.45 |
Price History
| 52-Week Change | -36.51 |
| 52-Week High | 46.91 |
| 52-Week Low | 7.91 |
| Moving Average 50 Days | 27.81 |
| Moving Average 200 Days | 33.27 |
Statistics
| Average Volume | 3,135 |
| Shares Outstanding | 112.21M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
